Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Hyperuricaemia
ADR ID BADD_A02167
ADR Hierarchy
14      Metabolism and nutrition disorders
14.09      Purine and pyrimidine metabolism disorders
14.09.01      Disorders of purine metabolism
14.09.01.003      Hyperuricaemia
Description Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT. [MeSH]
MedDRA Code 10020903
MeSH ID D033461
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Hyperuricaemia | Hyperuricaemic | Hyperuricemia
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D000032-phenylbutyric acid--
BADD_D00016Acamprosate--
BADD_D00017Acamprosate calcium--
BADD_D00062Aldesleukin--
BADD_D00066Alendronic acid0.000066%
BADD_D00105Amiloride hydrochloride--
BADD_D00121Amlodipine0.000016%
BADD_D00132Amphotericin b--
BADD_D00137Amsacrine--
BADD_D00165Aripiprazole--
BADD_D00178Atenolol--
BADD_D00193Axitinib0.000168%
BADD_D00194Azacitidine0.000112%
BADD_D00202Azilsartan medoxomil--
BADD_D00214Basiliximab--
BADD_D00223Belatacept--
BADD_D00230Bendamustine0.000112%
BADD_D00231Bendamustine hydrochloride--
BADD_D00232Bendroflumethiazide--
BADD_D00233Benicar hydrochlorothiazide--
BADD_D00235Benzalkonium chloride--
BADD_D00263Betaxolol--
BADD_D00269Bexarotene--
BADD_D00283Boceprevir--
BADD_D00284Bortezomib--
BADD_D00307Bumetanide--
BADD_D00318Busulfan--
BADD_D00330Cabozantinib0.000112%
BADD_D00346Candesartan--
BADD_D00347Candesartan cilexetil--
The 1th Page    1 2 3 4 5    Next   Last    Total 7 Pages